Atlas Trials

A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Clinical trial NCT05912933 · COMPLETED

Trial details

NCT number
NCT05912933
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2024-08-19
Primary completion
2024-08-30
Enrollment
1342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.